FIGURE

Fig. 7

ID
ZDB-FIG-230906-25
Publication
Jing et al., 2023 - Synthetic lethal targeting of TET2-mutant haematopoietic stem and progenitor cells by XPO1 inhibitors
Other Figures
All Figure Page
Back to All Figure Page
Fig. 7

Exportin 1 (XPO1) inhibitors selectively kill TET2-mutant MV4-11 cells. (A, B) TET2 wild-type (WT) MV4-11 leukaemia cells and two clones created using different CRISPR guides of CRISPR-cas9-induced, TET2-inactivated MV4-11 cells were cultured with different concentrations of selinexor (A) or eltanexor (B) for 72 h. Cell viability was measured with the Cell-Titre Glo assay and the inhibitory concentration at 50% (IC50) is indicated for each group. Data represent the mean ± SD of three independent experiments. (C) TET2 WT and -mutant MV4-11 clones were treated with dimethylsulfoxide (DMSO), or 20 nM selinexor or 20 nM eltanexor for 16 h (for cleaved PARP and cleaved-Caspase3) and analysed by western blot. This experiment was performed three times with qualitatively similar results. (D) TET2 WT and two independent clones of CRISPR-cas9-induced, TET2-mutant MV4-11 cells were plated on methylcellulose containing (DMSO, selinexor (20 nM) or eltanexor (20 nM). The total number of colony-forming units (CFUs) was determined after 7 days.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Br. J. Haematol.